When: $405 close on ≥1.3x average volume

Then: Flip to Hold — decisive 200 SMA reclaim ($396.72) plus psychological level plus volume confirmation

When: $350 close with volume

Then: Add to Underweight on weakness — consolidation failure / 50 SMA break signal

When: $298 close on volume ≥50M

Then: Downgrade to Sell — bear-case breakdown confirmation

Reduce gross exposure; sell into rallies toward $390-$400; cap position at 50% of Mag-7 basket average; only add on weakness toward $349-$361

• Operating margin TTM: 1.41%
• Forward P/E: 172x
• Net cash: $27.4 billion
• Short-term investments: $43.5 billion
• Annualized R&D: $9.5 billion
• Stock-based compensation: $2.83 billion
• Share count growth: 22% YoY
• Musk pay package creates additional future dilution: $1 trillion
• 200-day SMA: $396.72
• Stock sits 4.5% below 200 SMA
• 200 SMA rejected price 9 of last 10 sessions
• MACD: 5.57 (barely above zero)
• RSI: 60
• Today's volume: 28.1 million shares
• Prior meaningful move volume: 60-80+ million shares
• FOMC 'no cuts' probability priced at: 96%
• Beta: 1.85
• Energy storage first dispatch: 580 megawatts
• Mag-7 basket position size cap: 50%
• Aggressive trim range: $390-$400
• New position entry zones: $349-$361
• Stop level: $410
• Downside risk target: $300-$340
• Upside target (low probability): $420-$500
• EV/EBITDA multiple cited by aggressive case: 100-110x

→ vs aggressive: 172x forward P/E re-framing: Relabeling Tesla as an AI platform doesn't change cash flows; 1.41% operating margin is characteristic of a cyclical manufacturer, not an AI platform

→ vs aggressive: Investment grade trifecta: $27.4B net cash and $43.5B short-term investments were already priced in; IG upgrade confirms what was known, not a new catalyst; passive flows work both ways on macro shocks

→ vs aggressive: R&D as offset for dilution: $9.5B R&D plus $2.83B stock comp plus 22% YoY share growth plus $1T Musk pay package is extraordinary capital intensity into businesses with no current revenue contribution at scale

→ vs aggressive: Death cross interpretation: Stock is 4.5% below $396.72 200 SMA which has rejected price 9 of 10 sessions; this is an unyielding ceiling, not fading resistance

→ vs aggressive: Volatility squeeze: Squeezes resolve directionally but are not pre-loaded; MACD barely above zero at 5.57, RSI of 60 with room to fall, and low volume (28.1M vs 60-80M) rallies into upper Bollinger band statistically more likely to fade

→ vs aggressive: Macro argument: 'Fully priced' hawkish Fed means multiple cannot expand without actual easing surprise; symmetric risk if more hawkish than 96% implies; 1.85 beta hits Tesla harder on compression

→ vs aggressive: Upside asymmetry: Path to $420-$500 requires sustained reacceleration, expanding margins, AND willing buyers at higher multiples—low probability; path to $300-$340 on any disappointment is high probability

Trim 30-35% of TSLA position, reinvest trim proceeds into Mag-7 names with less-extreme valuations or hedge with March 2027 $340 puts (cost 3-5% of notional); maintain 35-45% of Mag-7 basket in TSLA; set pre-committed triggers at $396.72 (stop trimming, add back half trimmed position with $361 stop) and $361.72 (trim to 20% basket weighting).

• TTM operating margin at 1.41% with 348x trailing P/E creates asymmetric downside risk configuration
• Fortress balance sheet: $27.4B net cash, $43.5B short-term investments, current ratio 1.94
• IG (Fitch BBB) rating is largely priced in, not a new equity catalyst despite compressing credit spreads
• Volatility squeeze technicals are directionally neutral below declining 200 SMA at $396.72; RSI/MACD recovery is backtest curve-fitting risk
• Today's volume at 28.1M shares versus 60-80M on prior directional moves; price at upper Bollinger band $380.16; MACD barely positive at 5.57
• 22% YoY share count growth and $2.83B stock-based comp create real near-term dilution; $1T pay package adds future overhang
• Conservative analyst's $390 entry/$410 stop framing is contradictory (stop above entry); Q2 revenue reacceleration +25% YoY is a genuine inflection point
• Macro (hawkish Fed) is a wash for the trade; Polymarket pricing 96% no-cut probability, 8% recession odds
• Reinvestment into other Mag-7 names carries similar multiple compression risk; long-duration Treasuries carry TSLA re-capture opportunity cost
• Beta at 1.85 means full TSLA position already delivers significant directional exposure through volatility alone

→ vs aggressive: Tesla's operating margin has stayed near single digits since 2020 despite repeated 'FSD/Robotaxi/Optimus' transition narratives; TTM margin of 1.41% makes 348x trailing P/E a fragile configuration prone to 30-50% drawdowns on single-catalyst disappointment

→ vs aggressive: Volatility squeeze framing (MACD crossed positive, RSI recovered) is backtest curve-fitting; historical base rate for directional resolution below flat-to-declining 200 SMA is ~50/50, not bull-loaded; MACD at 5.57 barely above zero with volume at 28.1M (versus 60-80M on prior moves) reads as neutral coil, not bullish signal

→ vs conservative: Treating bear case as base case on a name with $27.4B net cash, 1.94 current ratio, and reaccelerating +25% YoY revenue structurally underweights a historically volatile-upside surprise name; Q2 2026 inflection is real, not narrative

→ vs conservative: Trade construction is internally inconsistent: entry at $390 with stop at $410 means stop above entry on a sell; 'trim 25-50% aggressively' without re-deployment guidance leaves capital in cash or forces valuation risk onto other stretched Mag-7 names

→ vs conservative: Dilution argument is won on the facts ($2.83B stock comp, 22% YoY share growth, $1T pay package), but conservative analyst's R&D offset framing (Optimus, Robotaxi, Cybercab) is equally uncertain and long-dated versus the near-term, quantifiable dilution cost